Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial
Lancet Psychiatry
Fecha de publicación: 11 March 2019
DOI: https://doi.org/10.1016/S2215-0366(19)30045-8
Autores: Prof Gill Livingston, MD., Julie Barber, PhD., Louise Marston, PhD
Aisling Stringer, MSc., Monica Panca, MSc., Rachael Hunter, MSc., Prof Claudia Cooper, PhD., Anne Laybourne, PhD., Francesca La Frenais, PhD., Suzanne Reeves, PhD., Monica Manela, BM., Katie Lambe, BSc
Background: Many people with dementia living in care homes have distressing and costly agitation symptoms. Interventions should be efficacious, scalable, and feasible.
